Cargando…

Real-world evaluation of patiromer utilization and its effects on serum potassium in veterans with end stage kidney disease

Hyperkalemia (serum potassium [K+] ≥5.1) is life-threatening in patients diagnosed with end stage kidney disease (ESKD). Patiromer is approved for the treatment of hyperkalemia, although its role in hyperkalemic patients with ESKD is not well understood. This study describes real-world patiromer uti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinnell, Derek, Patel, Shardool, Qualls, Joshua, Chen, Wei, Rathod, Anitha, Woods, Steven D., Boutin, Sylvie, Kovesdy, Csaba P., Tangri, Navdeep, Sauer, Brian C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	5200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771256/ https://www.ncbi.nlm.nih.gov/pubmed/36550897 http://dx.doi.org/10.1097/MD.0000000000032367

Ejemplares similares

Assessing patiromer utilization and associated serum potassium changes in US veterans with prior sodium polystyrene sulfonate exposure
por: Patel, Shardool, et al.
Publicado: (2023)

Justification for initiating patiromer when restricted by prior authorization and clinical guidance in a US health care system
por: Patel, Shardool, et al.
Publicado: (2022)

Real-World Evaluation of Patiromer for the Treatment of Hyperkalemia in Hemodialysis Patients
por: Kovesdy, Csaba P., et al.
Publicado: (2018)

Safety of potassium-bearing citrate in patients with renal transplantation: A case report
por: Wang, Lin, et al.
Publicado: (2017)

Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices
por: Shafi, Tariq, et al.
Publicado: (2017)

Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease
por: Chang, Po-Ya, et al.
Publicado: (2015)

Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure
por: Hwang, Jyh-Chang, et al.
Publicado: (2016)

Febuxostat-induced agranulocytosis in an end-stage renal disease patient: A case report
por: Poh, Xue Er, et al.
Publicado: (2017)

Intestinal tuberculosis in a patient with end-stage renal disease on hemodialysis: A case report
por: Lee, In Hee, et al.
Publicado: (2020)

The prevalence of constipation in end-stage kidney disease patients: A cross-sectional observation study
por: Zhang, Liuping, et al.
Publicado: (2022)

HLA types and their association with end-stage renal disease in Vietnamese patients: A cross-sectional study
por: Le Pham, Nhat-Minh, et al.
Publicado: (2022)

Association Between Chronic Osteomyelitis and Risk of End-Stage Renal Disease: A Nationwide Population-Based Cohort Study
por: Lin, Shih-Yi, et al.
Publicado: (2015)

Prevalence of glycemic variability and factors associated with the glycemic arrays among end-stage kidney disease patients on chronic hemodialysis
por: Yusof Khan, Abdul Hanif Khan, et al.
Publicado: (2021)

Reduced Stroke Risk After Parathyroidectomy in End-Stage Renal Disease: A 13-Year Population-Based Cohort Study
por: Hsu, Yueh-Han, et al.
Publicado: (2015)

Trends in the incidence and prevalence of end-stage renal disease with hemodialysis in entire Korean population: A nationwide population-based study
por: Choi, Hong Sang, et al.
Publicado: (2021)

Concurrent pituitary apoplexy and posterior reversible encephalopathy syndrome in a patient with end-stage renal disease on hemodialysis: A case report
por: Lee, In Hee, et al.
Publicado: (2020)

The effects of dialysis modality choice on cognitive functions in patients with end-stage renal failure: A protocol for systematic review and meta-analysis
por: Gao, Tongbin, et al.
Publicado: (2021)

Serum level of high mobility group box protein-1 and prognosis of patients with end-stage renal disease on hemodialysis and peritoneal dialysis
por: Chen, Linyan, et al.
Publicado: (2021)

Risk Factors Associated with End-Stage Renal Disease (ESRD) in Patients With Atherosclerotic Renal Artery Stenosis: A Nationwide Population-Based Analysis
por: Yu, Tung-Min, et al.
Publicado: (2015)

Associations between the serum magnesium and all-cause or cardiovascular mortality in chronic kidney disease and end-stage renal disease patients: A meta-analysis
por: Liu, Hongyan, et al.
Publicado: (2021)

Hemodialysis Is Associated With Increased Peripheral Artery Occlusive Disease Risk Among Patients With End-Stage Renal Disease: A Nationwide Population-Based Cohort Study
por: Lin, Chin-Sheng, et al.
Publicado: (2015)

Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study
por: Chang, Yu-Kang, et al.
Publicado: (2015)

Real-world treatment patterns of renal anemia in hemodialysis patients: A multicenter cohort study performed using DialysisNet (RRAHD study)
por: Kim, Hyo Jin, et al.
Publicado: (2020)

Different Risk of Common Gastrointestinal Disease Between Groups Undergoing Hemodialysis or Peritoneal Dialysis or With Non-End Stage Renal Disease: A Nationwide Population-Based Cohort Study
por: Lee, Yi-Che, et al.
Publicado: (2015)

The occurrence and potential predictive factors of major adverse cardiac and cerebral events in end-stage renal disease patients on continuous ambulatory peritoneal dialysis: A prospective cohort study
por: Yao, Chunmeng, et al.
Publicado: (2021)

Interaction Between Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Angiotensin-Converting Enzyme Inhibition on Survival in Hemodialyzed Patients
por: Kiss, István, et al.
Publicado: (2014)

Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia
por: Bushinsky, David A, et al.
Publicado: (2015)

Gut Microbiota and Host Cometabolism Are Altered by Patiromer-Induced Changes in Serum and Stool Potassium
por: Gao, Bei, et al.
Publicado: (2020)

Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life
por: Esteban‐Fernández, Alberto, et al.
Publicado: (2022)

Vitamin D Deficiency Is an Independent Risk Factor for Urinary Tract Infections After Renal Transplants
por: Kwon, Young Eun, et al.
Publicado: (2015)

Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 Cases
por: Dauvergne, Maxime, et al.
Publicado: (2015)

Changes in Echocardiographic Parameters According to the Rate of Residual Renal Function Decline in Incident Peritoneal Dialysis Patients
por: Koo, Hyang Mo, et al.
Publicado: (2015)

The Pivotal Role of a Novel Biomarker of Reactive Oxygen Species in Chronic Kidney Disease
por: Hirata, Yoshihiro, et al.
Publicado: (2015)

Association Between Vascular Access Dysfunction and Subsequent Major Adverse Cardiovascular Events in Patients on Hemodialysis: A Population-Based Nested Case–Control Study
por: Kuo, Te-Hui, et al.
Publicado: (2015)

Severity of Anemia Predicts Hospital Length of Stay but Not Readmission in Patients with Chronic Kidney Disease: A Retrospective Cohort Study
por: Garlo, Katherine, et al.
Publicado: (2015)

Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes
por: Venuto, Rocco C., et al.
Publicado: (2015)

A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection
por: Hsu, Ping-I, et al.
Publicado: (2015)

Refractive Results Using a New Optical Biometry Device: Comparison With Ultrasound Biometry Data
por: Aktas, Serdar, et al.
Publicado: (2015)

Single Shot Adductor Canal Block for Postoperative Analgesia of Pediatric Patellar Dislocation Surgery: A Case-Series Report
por: Chen, Jia-Yu, et al.
Publicado: (2015)

Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus
por: Tsai, Shang-Feng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pno4ab1scda1nf717ed8se8pc8